Astrazeneca Pharma India standalone net profit declines 32.06% in the June 2026 quarter
2026-08-10 17:04:29Astrazeneca Pharma India standalone net profit declines 32.06% in the June 2026 quarter business-standard.com...
Read MoreAnnouncement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
18-Sep-2026 | Source : BSEPlease find the enclosed intimation of the Company with respect to the captioned subject for your reference.
Closure of Trading Window
15-Sep-2026 | Source : BSEPlease find the enclosed intimation of the Company as per the captioned subject for your reference.
Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Resignation Of Senior Management Personnel
15-Sep-2026 | Source : BSEPlease find the enclosed intimation of the Company in relation to the captioned subject for your reference.
Corporate Actions
No Upcoming Board Meetings
Astrazeneca Pharma India Ltd has declared 1800% dividend, ex-date: 31 Jul 26
Astrazeneca Pharma India Ltd has announced 2:10 stock split, ex-date: 15 Jun 06
No Bonus history available
No Rights history available